Literature DB >> 12950599

A coordinated cytotoxic effect of IFN-gamma and cross-reactive antibodies in the pathogenesis of Helicobacter pylori gastritis.

Toshiyuki Itoh1, Masaru Yoshida, Tsutomu Chiba, Toru Kita, Yoshio Wakatsuki.   

Abstract

BACKGROUND: Helicobacter pylori (H. pylori) infection is associated with chronic infiltration into the stomach by T cells and plasma cells producing IFN-gamma and antibodies of various specificities, respectively. It is unknown whether these lymphocyte-products may play coordinated roles in the gastric pathology of this infection. AIMS: To know how IFN-gamma may relate to anti-H. pylori antibodies in their roles in pathogenesis, we determined the isotype subclass of those antibodies as well as their cross-reactivity and cytotoxicity to gastric epithelium. METHODS AND
RESULTS: We infected BALB/c mice with H. pylori (SS1, Sydney Strain 1) and generated monoclonal antibodies, which were comprised of 240 independent clones secreting immunoglobulin and included 80 clones reactive to SS1. Ninety percent of the SS1-reactive clones had IgG2a isotype. Two clones, 2B10 and 1A9, were cross reactive to cell surface antigens in H. pylori and to antigens of 28 KDa and 42 KDa, respectively, which were present on the cell surface of and shared by both mouse and human gastric epithelial cells. The antigens recognized by these monoclonal antibodies localized a distinctive area in the gastric glands. In the presence of complement, 2B10 showed cytotoxicity to gastric epithelial cells. The effect was dose dependant and augmented by IFN-gamma. Finally, administration of 2B10 to mice with SS1 infection aggravated gastritis by increasing cellular infiltration.
CONCLUSION: IFN-gamma by gastric T cells may participate in pathogenesis of the H. pylori infected stomach by directing an isotype-switch of anti-H. pylori antibodies to complement-binding subclass and by augmenting cytotoxic activity of a certain autoantibody. This may explain a host-dependent diversity in gastric pathology of the patients with H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12950599     DOI: 10.1046/j.1523-5378.2003.00154.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  5 in total

Review 1.  Host factors are important in determining clinical outcomes of Helicobacter pylori infection.

Authors:  Tsutomu Chiba; Hiroshi Seno; Hiroyuki Marusawa; Yoshio Wakatsuki; Kazuichi Okazaki
Journal:  J Gastroenterol       Date:  2006-01       Impact factor: 7.527

2.  Regulation of gastric B cell recruitment is dependent on IL-17 receptor A signaling in a model of chronic bacterial infection.

Authors:  Holly M Scott Algood; Shannon Sedberry Allen; Mary K Washington; Richard M Peek; Geraldine G Miller; Timothy L Cover
Journal:  J Immunol       Date:  2009-10-07       Impact factor: 5.422

3.  IL-17a and IL-22 Induce Expression of Antimicrobials in Gastrointestinal Epithelial Cells and May Contribute to Epithelial Cell Defense against Helicobacter pylori.

Authors:  Beverly R E A Dixon; Jana N Radin; M Blanca Piazuelo; Diana C Contreras; Holly M Scott Algood
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240

4.  Helicobacter pylori Resists the Antimicrobial Activity of Calprotectin via Lipid A Modification and Associated Biofilm Formation.

Authors:  Jennifer A Gaddy; Jana N Radin; Thomas W Cullen; Walter J Chazin; Eric P Skaar; M Stephen Trent; Holly M S Algood
Journal:  mBio       Date:  2015-12-08       Impact factor: 7.867

5.  Systems modeling of the role of interleukin-21 in the maintenance of effector CD4+ T cell responses during chronic Helicobacter pylori infection.

Authors:  Adria Carbo; Danyvid Olivares-Villagómez; Raquel Hontecillas; Josep Bassaganya-Riera; Rupesh Chaturvedi; M Blanca Piazuelo; Alberto Delgado; M Kay Washington; Keith T Wilson; Holly M Scott Algood
Journal:  MBio       Date:  2014-07-22       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.